Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10853616rdf:typepubmed:Citationlld:pubmed
pubmed-article:10853616lifeskim:mentionsumls-concept:C0013227lld:lifeskim
pubmed-article:10853616lifeskim:mentionsumls-concept:C0036866lld:lifeskim
pubmed-article:10853616lifeskim:mentionsumls-concept:C0022860lld:lifeskim
pubmed-article:10853616lifeskim:mentionsumls-concept:C0022702lld:lifeskim
pubmed-article:10853616lifeskim:mentionsumls-concept:C0376211lld:lifeskim
pubmed-article:10853616pubmed:issue6lld:pubmed
pubmed-article:10853616pubmed:dateCreated2000-9-28lld:pubmed
pubmed-article:10853616pubmed:abstractTextTo evaluate the impact of gender on labetalol kinetics.lld:pubmed
pubmed-article:10853616pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10853616pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10853616pubmed:languageenglld:pubmed
pubmed-article:10853616pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10853616pubmed:citationSubsetIMlld:pubmed
pubmed-article:10853616pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10853616pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10853616pubmed:statusMEDLINElld:pubmed
pubmed-article:10853616pubmed:monthJunlld:pubmed
pubmed-article:10853616pubmed:issn0277-0008lld:pubmed
pubmed-article:10853616pubmed:authorpubmed-author:SullivanJ MJMlld:pubmed
pubmed-article:10853616pubmed:authorpubmed-author:WolfeM SMSlld:pubmed
pubmed-article:10853616pubmed:authorpubmed-author:JohnsonJ AJAlld:pubmed
pubmed-article:10853616pubmed:authorpubmed-author:HerringV LVLlld:pubmed
pubmed-article:10853616pubmed:authorpubmed-author:AkersW SWSlld:pubmed
pubmed-article:10853616pubmed:issnTypePrintlld:pubmed
pubmed-article:10853616pubmed:volume20lld:pubmed
pubmed-article:10853616pubmed:ownerNLMlld:pubmed
pubmed-article:10853616pubmed:authorsCompleteYlld:pubmed
pubmed-article:10853616pubmed:pagination622-8lld:pubmed
pubmed-article:10853616pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:10853616pubmed:meshHeadingpubmed-meshheading:10853616...lld:pubmed
pubmed-article:10853616pubmed:meshHeadingpubmed-meshheading:10853616...lld:pubmed
pubmed-article:10853616pubmed:meshHeadingpubmed-meshheading:10853616...lld:pubmed
pubmed-article:10853616pubmed:meshHeadingpubmed-meshheading:10853616...lld:pubmed
pubmed-article:10853616pubmed:meshHeadingpubmed-meshheading:10853616...lld:pubmed
pubmed-article:10853616pubmed:meshHeadingpubmed-meshheading:10853616...lld:pubmed
pubmed-article:10853616pubmed:meshHeadingpubmed-meshheading:10853616...lld:pubmed
pubmed-article:10853616pubmed:meshHeadingpubmed-meshheading:10853616...lld:pubmed
pubmed-article:10853616pubmed:meshHeadingpubmed-meshheading:10853616...lld:pubmed
pubmed-article:10853616pubmed:meshHeadingpubmed-meshheading:10853616...lld:pubmed
pubmed-article:10853616pubmed:year2000lld:pubmed
pubmed-article:10853616pubmed:articleTitleGender differences in labetalol kinetics: importance of determining stereoisomer kinetics for racemic drugs.lld:pubmed
pubmed-article:10853616pubmed:affiliationDepartment of Clinical Pharmacy, College of Pharmacy, University of Tennessee, Memphis, USA.lld:pubmed
pubmed-article:10853616pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10853616pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:10853616pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:10853616pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:10853616pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed